Connexin32: a mediator of acetaminophen-induced liver injury?

References

• Asamoto M, Hokaiwado N, Murasaki T, et al. (2004). Connexin 32 dominant-negative mutant transgenic rats are resistant to hepatic damage by chemicals. Hepatology 40:205–10
   PubMed Web of Science ®Google Scholar
• Bajt ML, Knight TR, Farhood A, et al. (2003). Scavenging peroxynitrite with glutathione promotes regeneration and enhances survival during acetaminophen-induced liver injury in mice. J Pharmacol Exp Ther 307:67–73
   PubMed Web of Science ®Google Scholar
• Bajt ML, Lawson JA, Vonderfecht SL, et al. (2000). Protection against Fas receptor-mediated apoptosis in hepatocytes and nonparenchymal cells by a caspase-8 inhibitor in vivo: evidence for a postmitochondrial processing of caspase-8. Toxicol Sci 58:109–17
   PubMed Web of Science ®Google Scholar
• Blazka ME, Wilmer JL, Holladay SD, et al. (1995). Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 133:43–52
   PubMed Web of Science ®Google Scholar
• Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–54
   PubMed Web of Science ®Google Scholar
• Dagli ML, Yamasaki H, Krutovskikh V, et al. (2004). Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver. Carcinogenesis 25:483–92
   PubMed Web of Science ®Google Scholar
• Dahlin DC, Miwa GT, Lu AY, et al. (1984). N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA 81:1327–31
   PubMed Web of Science ®Google Scholar
• Decrock E, Vinken M, De Vuyst E, et al. (2009). Connexin-related signaling in cell death: to live or let die? Cell Death Differ 16:524–36
   PubMed Web of Science ®Google Scholar
• Dobrowolski R, Sasse P, Schrickel JW, et al. (2008). The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans. Hum Mol Genet 17:539–54
   PubMed Web of Science ®Google Scholar
• Evert M, Ott T, Temme A, et al. (2002). Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-deficient mice. Carcinogenesis 23:697–703
   PubMed Web of Science ®Google Scholar
• Gujral JS, Knight TR, Farhood A, et al. (2002). Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? Toxicol Sci 67:322–8
   PubMed Web of Science ®Google Scholar
• Harrill AH, Ross PK, Gatti DM, et al. (2009). Population-based discovery of toxicogenomics biomarkers for hepatotoxicity using a laboratory strain diversity panel. Toxicol Sci 110:235–43
   PubMed Web of Science ®Google Scholar
• Ichai P, Samuel D. (2011). Epidemiology of liver failure. Clin Res Hepatol Gastroenterol 35:610–17
   PubMed Web of Science ®Google Scholar
• Igarashi I, Maejima T, Kai K, et al. (2014). Role of connexin 32 in acetaminophen toxicity in a knockout mice model. Exp Toxicol Pathol 66:103–10
   PubMed Web of Science ®Google Scholar
• Jaeschke H. (1990). Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J Pharmacol Exp Ther 255:935–41
   PubMed Web of Science ®Google Scholar
• Jaeschke H, Mitchell JR. (1990). Use of isolated perfused organs in hypoxia and ischemia/reperfusion oxidant stress. Methods Enzymol 186:752–9
   PubMed Web of Science ®Google Scholar
• Knight TR, Kurtz A, Bajt ML, et al. (2001). Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. Toxicol Sci 62:212–20
   PubMed Web of Science ®Google Scholar
• Lee SS, Buters JT, Pineau T, et al. (1996). Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem 271:12063–7
   PubMed Web of Science ®Google Scholar
• Maes M, Decrock E, Cogliati B, et al. (2014). Connexin and pannexin (hemi)channels in the liver. Front Physiol 4:405
   PubMed Web of Science ®Google Scholar
• Maes M, Vinken M, Jaeschke H. (2016). Experimental models of hepatotoxicity related to acute liver failure. Toxicol Appl Pharmacol 290:86–97
   PubMed Web of Science ®Google Scholar
• McGill MR, Jaeschke H. (2014). Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients. Expert Opin Drug Metabol Toxicol 10:1005–17
   PubMed Web of Science ®Google Scholar
• McGill MR, Lebofsky M, Norris HRK, et al. (2013). Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications. Toxicol Appl Pharmacol 269:240–9
   PubMed Web of Science ®Google Scholar
• McGill MR, Williams CD, Xie Y, et al. (2012). Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharmacol 264:387–94
   PubMed Web of Science ®Google Scholar
• Mehendale HM. (2005). Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol Pathol 33:41–51
   PubMed Web of Science ®Google Scholar
• Mitchell JR, Jollow DJ, Potter WZ, et al. (1973). Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 187:211–17
   PubMed Web of Science ®Google Scholar
• Moennikes O, Buchmann A, Ott T, et al. (1999). The effect of connexin32 null mutation on hepatocarcinogenesis in different mouse strains. Carcinogenesis 20:1379–82
   PubMed Web of Science ®Google Scholar
• Mossanen JC, Tacke F. (2015). Acetaminophen-induced acute liver injury in mice. Lab Anim 49:30–6
   PubMed Web of Science ®Google Scholar
• Muldrew KL, James LP, Coop L, et al. (2002). Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection. Drug Metab Dispos 30:446–51
   PubMed Web of Science ®Google Scholar
• Naiki-Ito A, Asamoto M, Naiki T, et al. (2010). Gap junction dysfunction reduces acetaminophen hepatotoxicity with impact on apoptotic signaling and connexin 43 protein induction in rat. Toxicol Pathol 38:280–6
   PubMed Web of Science ®Google Scholar
• Nelles E, Butzler C, Jung D, et al. (1996). Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc Natl Acad Sci USA 93:9565–70
   PubMed Web of Science ®Google Scholar
• Neveu MJ, Babcock KL, Hertzberg EL, et al. (1994). Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters. Cancer Res 54:3145–52
   PubMed Web of Science ®Google Scholar
• Park WJ, Park JW, Erez-Roman R, et al. (2013). Protection of a ceramide synthase 2 null mouse from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalization. J Biol Chem 288:30904–16
   PubMed Web of Science ®Google Scholar
• Patel SJ, Milwid JM, King KR, et al. (2012). Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure. Nat Biotechnol 30:179–83
   PubMed Web of Science ®Google Scholar
• Rana S, Dringen R. (2007). Gap junction hemichannel-mediated release of glutathione from cultured rat astrocytes. Neurosci Lett 415:45–8
   PubMed Web of Science ®Google Scholar
• Shoda T, Mitsumori K, Onodera H, et al. (1999). The relationship between decrease in Cx32 and induction of P450 isozymes in the early phase of clofibrate hepatocarcinogenesis in the rat. Arch Toxicol 73:373–80
   PubMed Web of Science ®Google Scholar
• Shoda T, Mitsumori K, Onodera H, et al. (2000). Liver tumor-promoting effect of beta-naphthoflavone, a strong CYP 1A1/2 inducer, and the relationship between CYP 1A1/2 induction and Cx32 decrease in its hepatocarcinogenesis in the rat. Toxicol Pathol 28:540–7
   PubMed Web of Science ®Google Scholar
• Temme A, Buchmann A, Gabriel HD, et al. (1997). High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr Biol 7:713–16
   PubMed Web of Science ®Google Scholar
• Theocharis SE, Skopelitou AS, Margeli AP, et al. (1994). Proliferating cell nuclear antigen (PCNA) expression in regenerating rat liver after partial hepatectomy. Dig Dis Sci 39:245–52
   PubMed Web of Science ®Google Scholar
• Tong X, Lopez W, Ramachandran J, et al. (2015). Glutathione release through connexin hemichannels: implications for chemical modification of pores permeable to large molecules. J Gen Physiol 146:245–54
   PubMed Web of Science ®Google Scholar
• Vinken M, Decrock E, De Vuyst E, et al. (2010). Connexin32 hemichannels contribute to the apoptotic-to-necrotic transition during Fas-mediated hepatocyte cell death. Cell Mol Life Sci 67:907–18
   PubMed Web of Science ®Google Scholar
• Vinken M, Doktorova T, Decrock E, et al. (2009). Gap junctional intercellular communication as a target for liver toxicity and carcinogenicity. Crit Rev Biochem Mol Biol 44:201–22
   PubMed Web of Science ®Google Scholar
• Vinken M, Henkens T, De Rop E, et al. (2008). Biology and pathobiology of gap junctional channels in hepatocytes. Hepatology 47:1077–88
   PubMed Web of Science ®Google Scholar
• Xie Y, Ramachandran A, Breckenridge DG, et al. (2015). Inhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury. Toxicol Appl Pharmacol 286:1–9
   PubMed Web of Science ®Google Scholar